221 related articles for article (PubMed ID: 21420496)
1. Cellular fusion for gene delivery to SCA1 affected Purkinje neurons.
Chen KA; Cruz PE; Lanuto DJ; Flotte TR; Borchelt DR; Srivastava A; Zhang J; Steindler DA; Zheng T
Mol Cell Neurosci; 2011 May; 47(1):61-70. PubMed ID: 21420496
[TBL] [Abstract][Full Text] [Related]
2. The histone deacetylase HDAC3 is essential for Purkinje cell function, potentially complicating the use of HDAC inhibitors in SCA1.
Venkatraman A; Hu YS; Didonna A; Cvetanovic M; Krbanjevic A; Bilesimo P; Opal P
Hum Mol Genet; 2014 Jul; 23(14):3733-45. PubMed ID: 24594842
[TBL] [Abstract][Full Text] [Related]
3. Post-symptomatic Delivery of Brain-Derived Neurotrophic Factor (BDNF) Ameliorates Spinocerebellar Ataxia Type 1 (SCA1) Pathogenesis.
Sheeler C; Rosa JG; Borgenheimer E; Mellesmoen A; Rainwater O; Cvetanovic M
Cerebellum; 2021 Jun; 20(3):420-429. PubMed ID: 33394333
[TBL] [Abstract][Full Text] [Related]
4. Non-invasive detection of neurochemical changes prior to overt pathology in a mouse model of spinocerebellar ataxia type 1.
Emir UE; Brent Clark H; Vollmers ML; Eberly LE; Öz G
J Neurochem; 2013 Dec; 127(5):660-8. PubMed ID: 24032423
[TBL] [Abstract][Full Text] [Related]
5. Extensive fusion of haematopoietic cells with Purkinje neurons in response to chronic inflammation.
Johansson CB; Youssef S; Koleckar K; Holbrook C; Doyonnas R; Corbel SY; Steinman L; Rossi FM; Blau HM
Nat Cell Biol; 2008 May; 10(5):575-83. PubMed ID: 18425116
[TBL] [Abstract][Full Text] [Related]
6. Mesenchymal stem cells ameliorate cerebellar pathology in a mouse model of spinocerebellar ataxia type 1.
Matsuura S; Shuvaev AN; Iizuka A; Nakamura K; Hirai H
Cerebellum; 2014 Jun; 13(3):323-30. PubMed ID: 24242763
[TBL] [Abstract][Full Text] [Related]
7. BDNF is altered in a brain-region specific manner and rescues deficits in Spinocerebellar Ataxia Type 1.
Rosa JG; Hamel K; Soles A; Sheeler C; Borgenheimer E; Gilliat S; Sbrocco K; Ghanoum F; Handler HP; Forster C; Rainwater O; Cvetanovic M
Neurobiol Dis; 2023 Mar; 178():106023. PubMed ID: 36724861
[TBL] [Abstract][Full Text] [Related]
8. Altered calcium signaling in Bergmann glia contributes to spinocerebellar ataxia type-1 in a mouse model of SCA1.
Nanclares C; Noriega-Prieto JA; Labrada-Moncada FE; Cvetanovic M; Araque A; Kofuji P
Neurobiol Dis; 2023 Oct; 187():106318. PubMed ID: 37802154
[TBL] [Abstract][Full Text] [Related]
9. SUMO-1 interacts with mutant ataxin-1 and colocalizes to its aggregates in Purkinje cells of SCA1 transgenic mice.
Kang S; Hong S
Arch Ital Biol; 2010 Dec; 148(4):351-63. PubMed ID: 21308649
[TBL] [Abstract][Full Text] [Related]
10. Radiation damage increases Purkinje neuron heterokaryons in neonatal cerebellum.
Espejel S; Romero R; Alvarez-Buylla A
Ann Neurol; 2009 Jul; 66(1):100-9. PubMed ID: 19670439
[TBL] [Abstract][Full Text] [Related]
11. Cerebellar Heterogeneity and Selective vulnerability in Spinocerebellar Ataxia Type 1 (SCA1).
Hamel K; Moncada EL; Sheeler C; Rosa JG; Gilliat S; Zhang Y; Cvetanovic M
Neurobiol Dis; 2024 Jul; 197():106530. PubMed ID: 38750673
[TBL] [Abstract][Full Text] [Related]
12. Abnormalities in synaptic dynamics during development in a mouse model of spinocerebellar ataxia type 1.
Hatanaka Y; Watase K; Wada K; Nagai Y
Sci Rep; 2015 Nov; 5():16102. PubMed ID: 26531852
[TBL] [Abstract][Full Text] [Related]
13. Experimental Treatment with Edaravone in a Mouse Model of Spinocerebellar Ataxia 1.
Sucha M; Benediktova S; Tichanek F; Jedlicka J; Kapl S; Jelinkova D; Purkartova Z; Tuma J; Kuncova J; Cendelin J
Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445867
[TBL] [Abstract][Full Text] [Related]
14. Differential effects of Wnt-β-catenin signaling in Purkinje cells and Bergmann glia in spinocerebellar ataxia type 1.
Luttik K; Tejwani L; Ju H; Driessen T; Smeets CJLM; Edamakanti CR; Khan A; Yun J; Opal P; Lim J
Proc Natl Acad Sci U S A; 2022 Aug; 119(34):e2208513119. PubMed ID: 35969780
[TBL] [Abstract][Full Text] [Related]
15. Lithium therapy improves neurological function and hippocampal dendritic arborization in a spinocerebellar ataxia type 1 mouse model.
Watase K; Gatchel JR; Sun Y; Emamian E; Atkinson R; Richman R; Mizusawa H; Orr HT; Shaw C; Zoghbi HY
PLoS Med; 2007 May; 4(5):e182. PubMed ID: 17535104
[TBL] [Abstract][Full Text] [Related]
16. Purkinje cell COX deficiency and mtDNA depletion in an animal model of spinocerebellar ataxia type 1.
Ripolone M; Lucchini V; Ronchi D; Fagiolari G; Bordoni A; Fortunato F; Mondello S; Bonato S; Meregalli M; Torrente Y; Corti S; Comi GP; Moggio M; Sciacco M
J Neurosci Res; 2018 Sep; 96(9):1576-1585. PubMed ID: 30113722
[TBL] [Abstract][Full Text] [Related]
17. Progress in pathogenesis studies of spinocerebellar ataxia type 1.
Cummings CJ; Orr HT; Zoghbi HY
Philos Trans R Soc Lond B Biol Sci; 1999 Jun; 354(1386):1079-81. PubMed ID: 10434309
[TBL] [Abstract][Full Text] [Related]
18. Early activation of microglia and astrocytes in mouse models of spinocerebellar ataxia type 1.
Cvetanovic M; Ingram M; Orr H; Opal P
Neuroscience; 2015 Mar; 289():289-99. PubMed ID: 25595967
[TBL] [Abstract][Full Text] [Related]
19. Assessing the efficacy of specific cerebellomodulatory drugs for use as therapy for spinocerebellar ataxia type 1.
Nag N; Tarlac V; Storey E
Cerebellum; 2013 Feb; 12(1):74-82. PubMed ID: 22718440
[TBL] [Abstract][Full Text] [Related]
20. Dynamic molecular network analysis of iPSC-Purkinje cells differentiation delineates roles of ISG15 in SCA1 at the earliest stage.
Homma H; Yoshioka Y; Fujita K; Shirai S; Hama Y; Komano H; Saito Y; Yabe I; Okano H; Sasaki H; Tanaka H; Okazawa H
Commun Biol; 2024 Apr; 7(1):413. PubMed ID: 38594382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
